Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Interest Coverage Ratio (2016 - 2025)

Guided Therapeutics' Interest Coverage Ratio history spans 15 years, with the latest figure at 3.76 for Q3 2025.

  • For Q3 2025, Interest Coverage Ratio rose 27.62% year-over-year to 3.76; the TTM value through Sep 2025 reached 3.87, up 40.05%, while the annual FY2024 figure was 5.53, 55.51% up from the prior year.
  • Interest Coverage Ratio for Q3 2025 was 3.76 at Guided Therapeutics, up from 4.86 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 0.91 in Q3 2021 and bottomed at 21.83 in Q2 2023.
  • The 5-year median for Interest Coverage Ratio is 5.19 (2024), against an average of 6.66.
  • The largest annual shift saw Interest Coverage Ratio soared 65.31% in 2021 before it tumbled 763.85% in 2022.
  • A 5-year view of Interest Coverage Ratio shows it stood at 4.35 in 2021, then plummeted by 211.33% to 13.54 in 2022, then surged by 50.26% to 6.74 in 2023, then skyrocketed by 40.95% to 3.98 in 2024, then rose by 5.48% to 3.76 in 2025.
  • Per Business Quant, the three most recent readings for GTHP's Interest Coverage Ratio are 3.76 (Q3 2025), 4.86 (Q2 2025), and 2.82 (Q1 2025).